White Paper: Analysis of neoantigen-reactive T cells using the QuickSwitch™ custom tetramer kit
Kazuhiro Kakimi MD, PhD has been a leader in developing effective immunotherapies against cancer for the last 15 years in Japan.
In this whitepaper, he and his colleagues have reported that the QuickSwitch™ Custom Tetramers will become an essential tool for studies of neoantigens.
Related Blogs:
- Evaluating the biological activity of a cancer vaccine with the HLA-A*02:01 QuickSwitch™ Quant platform
- QuickSwitch™ – Quickly Create Custom Tetramers
- High-Quality Stock and Custom Peptides
Caltag Medsystems is the UK & Ireland distributor for MBL International. For more information please contact:T: +44 (0)1280 827460 | E: techsupport@caltagmedsystems.co.uk
White Paper: Analysis of neoantigen-reactive T cells using the QuickSwitch™ custom tetramer kit